CLASS III Device recall · Reported 14 Dec 2016 · FDA Enforcement Report

Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay recalled

OraSure Technologies is recalling Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Product is, distributed in Kansas, Virginia. The recall was initiated on 10 Nov 2016 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # 6654085
Quantity recalled4 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0722-2017
FDA event ID
75681
Recalling firm
OraSure Technologies, Bethlehem, PA
Classification
Class III
Status
Terminated
Recall initiated
10 Nov 2016
FDA classified
8 Dec 2016
Reported
14 Dec 2016
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Potency & Assay

Timeline

10 Nov 2016Recall initiated by company
8 Dec 2016Classified by FDA+28 days
14 Dec 2016Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Shipping error. Cocaine metabolite Microplate distributed instead of Barbiturate Microplate due to incorrect selection of Microplate during manufacturing.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Product is intended for use by clinical laboratories in the qualitative determination of barbiturates in oral fluids.

Where it was distributed

Distributed to KS, and VA

KansasVirginia

Questions about this recall

Is Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Product is recalled?

Yes. OraSure Technologies recalled Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Product is on 10 Nov 2016. The recall is Class III and its status is Terminated. Recall number Z-0722-2017.

Why was it recalled?

Shipping error. Cocaine metabolite Microplate distributed instead of Barbiturate Microplate due to incorrect selection of Microplate during manufacturing.

Which lots are affected?

Lot # 6654085

Where was it sold?

Distributed to KS, and VA

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from OraSure Technologies

All 10

Other Test Kits & Diagnostics recalls

All 2,656